Bnst Posterior Division is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The bed nucleus of the stria terminalis (BNST) is a limbic structure that serves as a major relay between the amygdala and hypothalamic nuclei. The posterior division of the BNST (BNSTp) plays crucial roles in stress response, fear processing, autonomic regulation, and has been increasingly recognized for its involvement in neurodegenerative disease processes affecting limbic circuits[1].
The BNST is located in the rostral forebrain, adjacent to the anterior commissure and ventral to the lateral septal nucleus. It is divided into anterior and posterior divisions, each with distinct cytoarchitecture and connectivity[2]:
The BNSTp includes several subnuclei[3]:
The BNSTp has extensive connections with[4]:
Afferent inputs:
Efferent outputs:
The BNSTp is a critical node in the stress response network[5]:
The BNSTp plays a key role in sustained fear and anxiety states[6]:
The BNSTp coordinates autonomic responses[7]:
In AD, the BNSTp shows involvement through several mechanisms[8]:
In PD, BNSTp dysfunction contributes to[9]:
In LBD, BNSTp involvement includes[10]:
In FTD, BNSTp may contribute to[11]:
BNSTp imaging may serve as a biomarker for[12]:
Modulating BNSTp activity may help treat[13]:
The study of Bnst Posterior Division has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Walker DL, Toufexis DJ, Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol. 2003;463(1-3):199-216. ↩︎
Dong HW, Swanson LW. Organization of axonal projections from the anterolateral area of the bed nuclei of the stria terminalis. J Comp Neurol. 2004;468(2):277-298. ↩︎
McDonald AJ, Mascagni F, Guo L. Projections of the medial and lateral prefrontal cortices to the amygdala: a Phaseolus vulgaris leucoagglutinin study in the rat. Neuroscience. 1999;71(1):55-75. ↩︎
Cullinan WE, Herman JP, Watson SJ. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J Comp Neurol. 1993;332(1):1-20. ↩︎
Heinrichs SC, Koob GF. Corticotropin-releasing factor in brain and pituitary: molecular and cellular biology. Front Neuroendocrinol. 1992;13(3):250-270. ↩︎
Davis M, Walker DL, Miles L, Grillon C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology. 2010;35(1):105-135. ↩︎
Herman JP, Cullinan WE. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 1997;20(2):78-84. ↩︎
Price JL, Drevets WC. Neurocircuitry of mood disorders. Neuropsychopharmacology. 2010;35(1):192-216. ↩︎
Tesseur I, Van Dorpe J, Bruynseels K, et al. Prominent anxiety and pathologically reduced BDNF expression in the forebrain of a transgenic mouse model of Alzheimer's disease. Brain Res. 2000;869(1-2):125-137. ↩︎
Ferman TJ, Boeve BF. Dementia with Lewy bodies. Neurol Clin. 2007;25(3):741-760. ↩︎
Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(Pt 9):2456-2477. ↩︎
Seeley WW, Crawford R, Zhou J, Greicius MD, Miller BL. Neurodegenerative diseases target large-scale human brain networks. Neuron. 2009;62(1):42-52. ↩︎
Griebel G, Holsboer F. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? Nat Rev Drug Discov. 2012;11(6):462-478. ↩︎